Company / Net Income
Zomedica Corp. Net Income History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$81.9M
FY2025
5-year range
-$81.9M / -$17.0M
FY2022-FY2025
Trend
-74.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has declined for 3 consecutive years, from -$17M in FY2022 to -$82M in FY2025.
Based on SEC 10-K filings.
-$82M in FY2025.
Declined from -$35M to -$82M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Zomedica Corp.'s net income has declined for 3 consecutive years.
- In FY2025, net income decreased 74.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$81.9M | -74.2% |
| FY2024 | -$47.0M | -36.1% |
| FY2023 | -$34.5M | -102.9% |
| FY2022 | -$17.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026